The SemPresto autoinjector epinephrine device attaches to smartphones with magnetic technology and could be used for allergic ...

What Is It, and Why Does It Matter? Fasenra (benralizumab), a targeted medicine called a monoclonal antibody, binds to and reduces levels of eosinophils, a type of immune cell that can cause ...

AstraZeneca’s Fasenra (benralizumab) has been approved by the US FDA for the treatment of adult and paediatric patients aged 12 years and older with hypereosinophilic syndrome (HES) without an ...

Benralizumab is now indicated for HES in patients aged ≥12 years when no identifiable non-hematologic secondary cause is present, administered as 30 mg subcutaneously every four weeks.

Diabetes hardware company embecta aims to look beyond insulin and reshape itself into a more varied drug delivery provider—and it’s kick-starting that effort with the acquisition of a global ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

Embecta, a company that develops diabetes management solutions, is moving into the auto-injection market with its latest planned acquisition. The Becton Dickinson & CO spinoff reported it would ...

Google’s latest addition to its Chrome browser puts generative AI behind the wheel and you in the passenger seat. The release of Auto Browse is part of Google’s continued integration of AI features ...

A new mold concept developed by Zahoransky is engineered to accelerate the mass production of housings for insulin pens and auto injectors in a space- and energy-efficient manner. The Z.Sonic turn ...

Princess U. Ogbogu, Division Chief of Pediatric Allergy, Immunology, and Rheumatology at University Hospitals Rainbow Babies and Children’s Hospital and Case Western Reserve University, Cleveland, OH, ...